Moderna Continues mRNA Norovirus “Vaccine” Trials Following Guillain-Barré Case
A first-ever norovirus “vaccine”—another experimental biological product produced by Moderna, Inc., using novel mRNA technology—may be on the horizon even though last month the U.S. Food and Drug Administration (FDA) paused Moderna’s late-stage clinical trial following a report of Guillain-Barré syndrome (GBS), a rare neurological side effect that has also surfaced in its RSV vaccine […]
Swedish Study Investigates Food Allergy Increases in Children But Big Questions Remain
An estimated 1 in 13 children in the United States now have food allergies, a 50 percent increase in the incidence of food allergies between 1997 and 2011. Food allergy researchers have suggested there are several factors contributing to this increase, including shifts toward more processed diets, insufficient levels of vitamin D from limited sun […]
FDA Approves Freeze-Dried Smallpox/Mpox Vaccine
On Mar. 31, 2025, the U.S. Food and Drug Administration (FDA) approved the freeze-dried formulation of Bavarian Nordic A/S’s Jynneos vaccine for smallpox and mpox (formerly monkey pox) in adults 18 years of age and older. The liquid-frozen formulation of the vaccine was approved by the FDA on Sept. 24, 2019, but that version requires […]
CDC Picks Thimerosal Researcher for Vaccines, Autism Study
On Mar. 7, 2025, the Associated Press and other media sources reported that the U.S. Centers for Disease Control and Prevention (CDC) is planning to conduct a study to determine possible links between vaccines and autism. In a prepared statement, the DHHS vaccine policymaking agency said that the “CDC will leave no stone unturned in its […]
Yale Study Links COVID Shots to “Alarming” Immune System Condition
While many medical professionals hail the COVID-19 shots as a life-saving breakthrough and key to ending the pandemic, reports of long term health problems similar to those suffered by people who were infected with the SARS-CoV-2 virus have persisted since the COVID biological was rolled out nationwide in early 2021. A wide range of clinical […]
NIH Cuts Funding for “Vaccine Hesitancy” Research
Certain areas of research funded by the U.S. National Institutes of Health (NIH) is being reduced or discontinued with the justification that these areas no longer align with the agency’s current priorities. One of the areas in which funding will be cut is millions of dollars in NIH grants for studying vaccine hesitancy and strategies […]